Monday, June 15, 2026

North Korea’s New Weapons Strategy: How Missile Tests Are Shaping Regional Tensions

North Korea escalates military tests, launching various missiles and developing new weapon systems, signaling modernization efforts.

Kim Jong Un’s Economic Vision: Why Coal and Cement Are Key to North Korea’s 5-Year Plan

Kim Jong Un highlights coal and cement industries during elections, emphasizing economic development in North Korea's new five-year plan.

LG Uplus Wins Red Dot Design Award for U+tv User Experience

LG Uplus's U+tv wins the main prize at the 2025 Red Dot Design Awards for its exceptional UX and innovative design in IPTV services.

Tag: rare

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Gene Editing Study Suggests New Treatment Path for Rare Krabbe Disease

A study reveals adenine base editing may treat Krabbe disease, offering hope for rare genetic disorders through precise gene correction.

Samsung’s G-CROWN Platform is Revolutionizing Gene Therapy for Rare Diseases in Asia

Samsung Medical Center launches G-CROWN platform to develop gene therapies for rare diseases, aiming to reduce reliance on imports.

YH35995: A Game-Changer for Gaucher Disease? FDA Grants Orphan Drug Designation

Yuhan Corp's YH35995 for Gaucher disease receives orphan drug designation, enhancing its development for rare diseases with unmet needs.

Unlocking Genetic Insights: Family Insight Test Launches for High-Risk Families in Asia

3billion launches the Family Insight Test, a genomic diagnostic tool for high-risk families, enhancing genetic risk assessment and family planning.

1 Trillion KRW Donation: How the Lee Kun-hee Legacy is Transforming Infectious Disease Research in Korea

Samsung's donation aids childhood cancer and rare diseases, funding research and infrastructure to combat infectious diseases in South Korea.

3Billion Partners with Austin: What This Means for Rare Disease Diagnostics in the U.S.

3Billion partners with Austin for a new lab to enhance rare disease diagnostics and expand its U.S. market presence.

Unlocking Rare Diseases: How AI and Whole Genome Sequencing Achieved 46.2% Diagnostic Success in Korea

Three Billion, an AI-based rare disease diagnostic company, collaborates with Seoul National University Hospital on a major genomic study.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.